Emily Berry

Progestins Activate the AKT Pathway in Leiomyoma Cells and Promote Survival

Anna V. Hoekstra, Elizabeth C. Sefton, Emily Berry et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 93 citations · Full text

Life Sciences, Cell Biology, Endocrinology +16

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 86 citations · Full text

Medicine, Gynecology, Oncology +11

FGFR3–TACC3: A novel gene fusion in cervical cancer

Benedito A. Carneiro, Julia A. Elvin, Suneel D. Kamath et al. · Gynecologic Oncology Reports · 2015 · 76 citations · Full text

Medicine, Molecular Genetics, Oncology +17

A Comparison of Survival and Recurrence Outcomes in Patients With Endometrial Cancer Undergoing Robotic Versus Open Surgery

Hyo K. Park, Irene Helenowski, Emily Berry et al. · Journal of Minimally Invasive Gynecology · 2015 · 35 citations

Medicine, Oncology, Surgery +12

A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study

Roisin E. O’Cearbhaill, Wei Deng, Lee-may Chen et al. · Gynecologic Oncology · 2019 · 28 citations · Full text

Veterinary Medicine, Gynecology, Oncology +17